Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Alzheimer Disease

Alzheimer’s drugs rejected for NHS because benefits ‘too small’ to justify cost

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s.

Evening Standard

How a hated bacteria could protect the brain from Alzheimer’s disease

Helicobacter pylori – a bacteria best known for causing stomach ulcers – could lead to a new strategy in the fight against Alzheimer’s disease

The Independent UK

Alzheimer’s: bacteria that causes stomach ulcers may protect the brain, our new research indicates

Every three seconds, someone in the world develops dementia. Alzheimer’s disease is the most common form of dementia, accounting for between 60% and 70% of all cases.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

There's a new blood test for Alzheimer's. Here's everything you need to know about it.

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests.

LiveScience

New Alzheimer’s Blood Test Leads To Early Detection And Treatment

A new Alzheimer’s blood test recently approved by the U. S. Food and Drug Administration (FDA) can now detect the disease in people with early...

Saving Advice

Blood test for Alzheimer’s could soon be available on the NHS

New study shows test is 95 per cent accurate in picking up people with memory problems

The Independent UK

Alzheimer’s blood test ‘can accurately pick up early symptoms’

Researchers found the blood test was 95% accurate in picking up people with the disease, with very few cases missed.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Six crucial facts about Alzheimer’s and why there’s new hope for treatments

There was an 11% increase in Alzheimer’s disease clinical trials scheduled for 2025

The Independent UK

‘Hope on the horizon’ as drugs assessed for Alzheimer’s prevention

There has been an 11% increase in the number of clinical trials assessing potential treatments.

Evening Standard

The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?

This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.

The Conversation

Australia approves new drug to treat early Alzheimer’s disease

Kisunla is first new treatment registered by TGA in 25 years but could cost patients more than $80,000 and less than one in five will be eligible

The Guardian - AU

Could cold sores increase the risk of Alzheimer’s disease? A new study is no cause for panic

A new study has found the herpes simplex virus type 1 (HSV-1), which causes cold sores, may be linked to the development of Alzheimer’s disease.

The Conversation

Scientists ‘slash risk of Alzheimer’s’ with medicine used to treat cold sores

Researchers made a surprising connection between certain viral diseases and Alzheimer’s

The Independent UK

Treating cold sores with anti-virals ‘may slash risk of developing Alzheimer’s’

A study found that people who had suffered the herpes virus had an 80% increased risk of Alzheimer’s disease.

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Should AD stand for Alzheimer’s disease, or for Auguste Deter, the patient whose case was first described?

Auguste Deter was born 175 years ago on May 16, 1850. Though the story of her life is not widely known, it should be. Through her suffering and dignity, Deter puts a much-needed human face on the tragedy of Alzheimer’s disease (AD), one of the most important medical problems currently…

The Conversation

Do people really want to know their risk of getting Alzheimer’s?

A new study has highlighted the complex emotions and ethical dilemmas of learning your future risk of Alzheimer’s disease. Among 274 healthy research participants from the US aged 65 and over, 40% declined to receive their personal risk estimates – despite having initially expressed an interest in doing so.

The Conversation

Alzheimer’s: certain combinations of prescription drugs may slow progression of the disease, says mice study

Millions of older adults take five or more prescription drugs every day to manage chronic illnesses. While polypharmacy is often necessary, this practice has also been linked to many negative health outcomes in older adults – including memory problems, increased risk of falls and greater frailty.

The Independent UK

How menopause symptoms could predict women’s risk of dementia

ANALYSIS: Menopause can provide early warning signs, write Jasper Crockford, Maryam Ghahremani and Zahinoor Ismail

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

Diabetes drugs offer new hope for Aussies with dementia

Diabetes treatments are offering a glimmer of hope for a degenerative brain condition set to affect more than 800,000 Australians by the middle of the century.

The Conversation

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. Treatment options remain limited.

The Independent UK

New drug could reduce risk of early-onset Alzheimer’s disease

The results boost hopes similar treatments being developed to target more common forms of Alzheimer's - that appear when people reach their sixties, seventies and eighties - might also be effective.

The Conversation

Changes to speech and language can help detect Alzheimer’s early – here are five things to look out for

Ten million people are diagnosed with dementia worldwide each year – that’s more than ever. According to the Alzheimer’s Society approximately one million people in the UK are currently living with the disease. Studies predict this figure will rise to 1.6 million people by 2050.

The Guardian - US

Alzheimer’s research centers face Trump-imposed $65m funding delay across the US

Researchers report difficulties retaining staff as White House cost-cutting stresses US medical research system

The Times of India

Can a 19-year-old develop Alzheimer's disease? What causes early-onset disease in young

Alzheimer's disease is known to affect the elderly, and one would never expect a teenage individual to develop the neurodegenerative condition. However, this extremely rare case happened in China, and the researchers are yet to understand its underlying cause.

The Times of India

Could Alzheimer’s begin in your mouth? Research uncovers a potential bacterial trigger

Can you get Alzheimer's disease from a gum infection? While the link may seem far-fetched, a new study has uncovered this lesser-known connection, offering clues to the roots of the neurodegenerative disease.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

the Alzheimer Society

44 stories

the Alzheimer Association

37 stories

The Therapeutic Goods Administration

23 stories

Alzheimer Association

19 stories

University of Calgary

15 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.